Drosophila
Introduction
The Myb protein family is composed of sequence specific transcription factors that act to regulate the cell cycle and differentiation throughout development. Myb proteins have also been implicated in human cancers (Ganter and Lipsick, 1999; Lyon et al., 1994; Oh and Reddy, 1999) . In mammals, this small family of transcription factors consists of c-Myb (MYB), AMyb (MYBL1), and B-Myb (MYBL2). In contrast, only one gene encoding a Myb protein, Dm myb, has been identified in Drosophila melanogaster (Katzen et al., 1985) . The Drosophila Myb protein, DMyb, is a sequence specific transcription factor that acts to regulate the cell cycle and differentiation throughout development (Katzen, 2004) . DMyb shares substantial homology with mammalian Myb proteins in four domains, with the most extensive homology being in the DNA-binding domain (Katzen, 2004) . Dm myb mRNA is expressed in all mitotically active tissues throughout development, in adult ovaries and testes, and in some post mitotic tissues, but was not detected in late third instar larval 0925-4773/$ -see front matter Ó 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2008.02.005 polytene tissues such as the salivary gland (Katzen and Bishop, 1996) . We and others have previously demonstrated that DMyb has important roles in regulating the proliferation and/or development of cells in imaginal discs, salivary glands, abdominal histoblasts, and ovaries (Beall et al., 2002; Fitzpatrick et al., 2002; Fung et al., 2002 Fung et al., , 2003 Katzen et al., 1998; Manak et al., 2002; Okada et al., 2002) . Evidence from a combination of cellular, genetic, molecular, and biochemical analyses indicate that DMyb functions at multiple stages of the cell cycle. Loss of DMyb function in temperature-sensitive mutants causes cells to proliferate more slowly (Fung et al., 2002; Katzen et al., 1998) . Cellular defects in proliferating cells and genetic interactions with cell-cycle regulators indicate that DMyb is involved in regulating the G2/M transition and progression through mitosis (Fung et al., 2002; Katzen et al., 1998) . For example, reductions in DMyb function can be compensated for by overexpression of CDK1/Cdc2 and String/ Cdc25, both regulators of the G2/M transition (Katzen et al., 1998) ; studies in the eye disc indicate that DMyb regulates expression of cyclin B, a key regulator of the G2/M transition (Okada et al., 2002) ; and ectopic expression of DMyb has been shown to promote mitosis, even in G2 arrested cells (Fitzpatrick et al., 2002) .
Myb proteins have also been shown to have a function in regulating DNA replication in various developmental contexts. Vertebrate Myb proteins have been implicated in promoting the G1/S transition (Bessa et al., 2001) . Ectopic expression of DMyb promotes increased S phase in imaginal discs and can overcome a G1 block within the zone of nonproliferating cells (ZNC) in the wing disc (Fitzpatrick et al., 2002) . Conversely, high levels of ectopically expressed DMyb suppress endoreplication in the salivary gland (Fitzpatrick et al., 2002) . Biochemically, DMyb was identified as a member of a complex of proteins that includes Mip130/twilight, Mip120, Mip40, and p55/Caf1 (Mip = Myb interacting protein). This complex, dubbed the Myb complex, has been shown to bind to and regulate the critical control elements that are required for appropriate chorion gene amplification (Beall et al., , 2002 . The Myb complex has also been found as part of a larger complex called dREAM (Drosophila RBF, E2F, and Myb interacting proteins), which acts to repress transcription of some E2F regulated genes (Lewis et al., 2004) . Current evidence, which suggests that DMyb is a silent partner in the repression of these genes, does not preclude the possibility of DMyb playing a more active role in other contexts.
The synthesis and degradation of many cell-cycle regulators have themselves been shown to be subject to cell cycle regulation. A classic example of this are the cyclin proteins, which are regulated both transcriptionally and post-translationally. At the transcriptional level, regulation of cyclin E expression by E2F/DP during G1 is required for the G1 to S transition (Duronio et al., 1996; Duronio and O'Farrell, 1995) , and cyclin A is transcriptionally regulated by DNA Replication-related Element binding Factor (DREF), a protein known to activate genes necessary for S phase Ohno et al., 1996) . The functional importance of cell-cycle Fig. 1 -The DMyb protein is localized to the nuclei of proliferating and actively replicating cells throughout development. Shown are embryos (A and B) and tissues dissected from larvae (C-E) that were doubly stained with dN-17 DMyb antisera (red in merged images) and DAPI to visualize nuclei (green in merged images). (A) Cellular blastoderm embryo: DMyb was present at roughly equivalent levels in all of the nuclei at the surface, but was present at especially high levels in the pole cells (pc; indicated by arrow in inset). (B) Germ band extended embryo: high levels of DMyb were present in the G2 arrested stellate amnioserosal cells (indicated by yellow arrows) at this stage and throughout embryogenesis. (C) Third instar larval wing disc: the DMyb protein was present at relatively uniform levels in imaginal disc cells. (D) Second instar larval salivary gland: high levels of DMyb protein were detected in all nuclei at this stage when the nuclei are still undergoing active replication. (E) BrdU labeling (red in merge) of second instar larval salivary gland: only a subset of nuclei are undergoing endoreplication at any given time. (F) Third instar larval salivary gland: no DMyb was detected in the polyploid cell nuclei at this stage when endoreplication is nearing completion or has been completed. Inset: Mitotic imaginal ring (ir) cells from third instar larval salivary glands still have DMyb present. Scale bars: A and B, 0.02 mm; C, 0.01 mm; D, E, and F, 0.05 mm. dependent protein degradation is best exemplified by the mitotic cyclins A, B, and B3, which are degraded sequentially during mitosis in Drosophila embryos. When non-degradable forms of the cyclins A, B, and B3 are expressed in the Drosophila embryo, the cell cycle arrests during metaphase, early anaphase, and just prior to the onset of telophase, respectively, demonstrating that degradation of these cyclins is essential for appropriate progression through mitosis (Sigrist et al., 1995) . This degradation occurs through the function of the Anaphase Promoting Complex/Cyclosome (APC/C), a large multiprotein complex that promotes the degradation of many proteins at specific points in the cell cycle through ubiquitination and subsequent degradation by the 26S proteasome (Peters, 2002) . APC/C activity is highly regulated, and its role in targeting certain proteins for degradation at specific time points during cell division is required for exit from mitosis. APC/C substrate specificity is conferred by the adaptor proteins encoded by fizzy (fzy) and fizzy-related (fzr) genes, which both activate and target its function (Huang and Raff, 2002) . Following polyubiquitination by the APC/C complex, cyclins are degraded by the proteasome.
Many studies have shown that mammalian myb transcripts are regulated in a cell-cycle dependent manner (Catron et al., 1992; Lam et al., 1995 Lam et al., , 1992 Robinson et al., 1996) . Although DREF, a transcription factor known to regulate an array of proteins required for S phase, has been shown to be a regulator for Dm myb expression, the levels of Dm myb mRNA are relatively uniform in cellularized Drosophila embryos even though groups of cells are known to be at different stages of the cell cycle (Katzen and Bishop, 1996; Sharkov et al., 2002) . Therefore, we became interested in whether the DMyb protein might be subject to regulation via cell-cycle dependent degradation, especially as there are some indications that mammalian Myb proteins might be subject to such regulation. For example, ectopically expressed c-Myb has been reported to be degraded by the 26S proteasome (Bies and Wolff, 1997) , and ectopic B-Myb has been shown to be degraded during the cell cycle by the action of cyclin A/CDK2 acting in concert with the Cdc34-SCF p45Skp2 pathway after S phase completion (Charrasse et al., 2000) . However, the physiological relevance and generality of these findings is unclear since for these studies, the relevant proteins were ectopically expressed at high levels in cultured cells. We have investigated the distribution, subcellular localization, and stability of the endogenous DMyb protein in canonical and modified cell cycles during Drosophila development. We found DMyb localized to the nucleus in all examined tissues that were undergoing active endoreplication or proliferation. In the former, DMyb is continuously present, but the levels diminish as endoreplication nears completion. In the latter, DMyb is repeatedly degraded in an APC/C dependent manner between prophase and metaphase of mitosis, reappearing only after the completion of telophase. We also found that Mip130, another member of the Myb complex, colocalizes with DMyb (punctuate staining and excluded from certain regions of the nucleus), and that its levels change in the same cell-cycle dependent fashion as DMyb. This pattern of regulation by cell-cycle specific degradation is reminiscent of the mitotic cyclins, which undergo sequential APC/C dependent degradation at specific stages of mitosis. Despite the apparent similarities, however, there appear to be mechanistic differences, since unlike the mitotic cyclins, destruction of the DMyb protein does not appear to require either the Fzy or Fzr APC/C adaptor proteins.
Results

DMyb is expressed in mitotic tissues throughout development
We have previously reported generation of two anti-DMyb sera, DMyb(DBD) and DMyb(1.25RI), which are useful for detecting the DMyb protein in Western blots and in cultured cells by immunocytochemistry (Jackson et al., 2001 ). The DMyb(1.25RI) antisera has been characterized in embryos and is known to stain the nuclei of Schneider cells (Jackson Fig. 2 -The DMyb protein is degraded during prometaphase throughout syncytial development. (A) Wild type embryo in tenth nuclear division cycle stained for antibodies against DMyb (red in merge) and a-tubulin (green in merge) and DAPI (blue in merge) to stain DNA. DMyb was localized to the nucleus during S phase. During prophase, DMyb was still nuclear but staining intensity was slightly reduced. During prometaphase as the spindles begin to form, there was a rapid disappearance of the DMyb protein. By the time the chromosomes were aligned to the metaphase plate, DMyb protein was undetectable. DMyb continued to be undetectable through anaphase and telophase, until S phase of the subsequent mitotic division cycle commenced. Scale bar: 0.01 mm. (B) DMyb protein levels are reduced during mitosis. Embryos were fixed, stained with Hoechst, and sorted based on stage of mitosis (see Section 4). Shown is an immunoblot from pooled embryos staged at interphase, metaphase, and anaphase/telophase of mitotic cycles 8-12. The DMyb protein was present during interphase, but by metaphase, DMyb was no longer detectable. DMyb was still undetectable during anaphase and telophase. Alphatubulin is the loading control. (C) DMyb turnover is similar to that of Cyclin A in wild type embryos. Syncytial-stage embryos (0-to 60-min-old, cycles 4-8) were either untreated (DMSO control), treated with cycloheximide (+cyc), or treated with colchicine and cycloheximide sequentially (+col, +cyc). Extracts from homogenized embryos were separated on denaturing gels and Western blotted for expression of DMyb, Cyclin A and a-tubulin (loading control). Relative levels of Cyclin A and DMyb were calculated after correcting for differences in a-tubulin levels. As has been previously demonstrated for Cyclin A which is known to undergo rapid turnover (Su et al., 1999) , its levels decreased to 0.38 times the level in the DMSO control lane in the presence of cycloheximide (+cyc), which inhibits protein synthesis. Similarly, DMyb levels were reduced to 0.20 times that of the DMSO lane after cyclohexamide treatment. The reductions in both Cyclin A and DMyb protein levels were more pronounced when the embryos were first incubated in colchicine to induce metaphase arrest, and subsequently incubated in cycloheximide (+col, +cyc): to 0.12 and 0.04 times that of control lanes, respectively. et al., 2001) . Unfortunately, in larval tissues, the non-specific staining observed in immunohistochemical experiments with these antibodies was too high to reliably monitor endogenous DMyb protein. However, we have obtained superior results with a commercially available antibody, dN-17 (Santa Cruz Biotechnology), directed against 17 N-terminal amino acid residues of DMyb. As shown in Supplemental Fig. 1A , this antibody produced a strong nuclear DMyb signal in early embryos, and this reactivity was efficiently blocked by the 17 Nterminal amino acid peptide that had been used to generate the antibody. Furthermore, DMyb was readily detected by the DN-17 antibody in wing disc cells, whereas no signal was detected in a mitotic clone of cells that was homozygous for a null allele of Dm myb, thereby demonstrating the specificity of this antibody to the endogenous DMyb protein (Supplemental Fig. 1C and D) . Strikingly, endogenous DMyb protein was not detected in Dm myb null clones, even after a single cell division (data not shown), indicating that DMyb protein does not perdure.
We have previously reported that myb transcripts are present at fairly uniform levels throughout early embryogenesis and are present in proliferating cells throughout development, but undetectable in the endoreplicating tissues of late third instar larva (Katzen and Bishop, 1996) . Since transcript quantities do not always accurately reflect protein levels due to other types of regulation, we have now examined the DMyb protein directly. In agreement with the RNA data, the DMyb protein was present at fairly uniform levels throughout pre-cellularized embryos (though not uniform with respect to nuclear cycle stage; see below), cellularized embryos and discs ( Fig. 1) . However, DMyb protein levels were exceptionally high in a subset of tissues, such as pole cells and amnioserosal cells, a differential that is not reflected in the more uniform RNA levels (compare Fig. 1 and Supplemental Fig. 2 ). In contrast, the DMyb protein was not detected in the polyploid salivary glands and fat body of climbing third instar larvae, but was found in the imaginal ring cell nuclei located at the proximal end of the larval salivary gland, which are still mitotically active at this stage (Fig. 1F) .
The lack of detectable Dm myb transcripts or protein in polyploid tissues of climbing third instar larvae, along with our previous findings that high levels of ectopically expressed DMyb can suppress endoreplication in salivary glands (Fitzpatrick et al., 2002) , suggest that DMyb may not be required for endoreplication. However, since other studies have implicated DMyb in replication processes, we decided to look earlier in development. We found that in second instar larval salivary gland nuclei, which are undergoing more active endoreplication, the DMyb protein was easily detectable, indicating that DMyb could play a role in endoreplication (Fig. 1D ). The levels of DMyb protein were uniform in all of the second instar larval salivary gland nuclei, even though BrdU staining at this stage reveals that only a subset of the salivary gland nuclei are in S phase at any given time (Fig. 1E ). These findings suggest that regulation of DMyb levels does not play a role in regulating endoreplicative cell cycles.
Degradation of DMyb during syncytial division cycles
The natural synchronization of cell cycles stages during early Drosophila embryogenesis provides an ideal setting for examination of cell-cycle related gene products. The beginning of Drosophila embryogenesis is characterized by a rapid succession of 13 synchronized nuclear division cycles, consisting of replication and mitosis without intervening gap phases. These modified cycles occur without zygotic transcription and rely on proteins which are translated from maternally derived messenger RNA present in the eggs. To evaluate the DMyb protein within the context of these nuclear division cycles, we simultaneously stained with antibodies directed against DMyb and either a-tubulin ( Fig. 2A) , or antiphosphohistone H3 (PH3, data not shown). We observed cell cycle stage-specific fluctuations in DMyb levels during the syncytial mitotic cycles of preblastoderm Drosophila embryos. The DMyb protein was localized to the nucleus during S phase and the subsequent prophase. During prometaphase (as determined by spindle formation and nuclear envelope breakdown; Hiraoka et al., 1990) , it was rapidly degraded, and was not detectable again until after the completion of telophase. The DMyb protein could be observed in all nuclei by the beginning of the following S phase. Note that the staining of DMyb within the nucleus was often punctate (see Figs. 2A, 3, 7C) , the significance of which is currently unclear.
In order to assess the quantitative degradation of DMyb protein during syncytial division cycles, we collected wild type embryos, rapidly fixed in methanol, stained with Hoechst 33258 to visualize DNA, and sorted according to the phase of mitosis that the nuclei were undergoing. Western blot analysis showed that DMyb protein was present in the embryos during interphase, but by metaphase DMyb protein had been completely degraded (Fig. 2B ). DMyb was also undetectable in embryos undergoing anaphase and telophase. These results confirmed that the findings from analysis of the embryos using immunofluorescence reflected a bonafide loss of the DMyb protein.
This periodic degradation of DMyb, which was observed in all nuclear division cycles prior to cellularization, is similar but not identical to that of the degradation of cyclins in early embryos. For example, maternal Cyclin B protein is degraded around the mitotic spindles at the metaphase-anaphase transition during mitoses of syncytial division cycles (MaldonadoCodina and Glover, 1992); and similarly to DMyb, Cyclin A was shown to be degraded by metaphase, but only in late nuclear division cycles (Stiffler et al., 1999) . This correlation suggests that DMyb may be regulated by a similar mechanism as the mitotic cyclins. To begin to assess this, we used the approach developed for the analysis of Cyclin A protein dynamics during the cell cycle (Edgar et al., 1994b; Su et al., 1999) . As has been previously shown for Cyclin A, DMyb levels were substantially reduced in Western blot analysis when early embryos were treated with the protein synthesis inhibitor cycloheximide, indicating that the DMyb protein is unstable and must be continuously synthesized to maintain the steady state levels observed in interphase nuclei (Fig. 2C, +cyc) . Furthermore, when the embryos were first treated with colchicine to induce metaphase arrest, DMyb decreased to virtually undetectable levels, a result that correlates well with the behavior of Cyclin A (Edgar et al., 1994a,b; Su et al., 1999 ; and see Fig. 2C , +col,+cyc).
DMyb is degraded during mitosis throughout development
As noted above, the ''cell cycles'' occurring in early Drosophila embryos are atypical in that the egg is a single ''cell'' with a syncytium of nuclei that progress through S and M phases without cytokinesis. Therefore, to explore the generality of our findings, we shifted our focus to the localization of DMyb protein in the more traditional cell cycles that begin after cellularization, which occurs after the first thirteen nuclear division cycles. Unlike the earlier synchronized cycles, mitotic division cycle 14 is characterized by mitotic domains, which are reproducible spatio-temporal patterns of mitosis that occur throughout the remainder of embryonic develop-ment (Foe, 1989) . Mitotic domain patterns are regulated by Cdc25/String (Edgar et al., 1994a) . The results for the DMyb protein were the same in cycle 14 embryos as in syncytial embryos (Fig. 3) . Briefly, DMyb was present in the nuclei of cells that were in either G2 or S phase (there is no G1 phase at this stage of development). DMyb could still be observed in the nucleus during prophase of mitosis, but was undetectable by metaphase and was not present during anaphase and telophase. RNA in situ hybridization experiments were done to look at levels of Dm myb RNA in mitotic domains (Fig. 3B) . These experiments confirmed our previous findings that the level of Dm myb RNA is fairly uniform during this stage (Katzen and Bishop, 1996) , and not reduced in mitotic domains, thereby indicating that the regulation of DMyb during mitosis is not at the level of transcript abundance. We have also observed loss of DMyb at prometaphase of mitosis in larval tissues (Fig. 3C) , which suggests that a similar mechanism of regulation by degradation of DMyb is employed in both the embryonic and larval developmental stages.
Based on these findings, we decided to examine the localization and levels of Mip130, the component of the Myb complex that DMyb activity has been reported to antagonize Lewis et al., 2004) . Using an antibody that specifically binds to the Mip130 protein (see Supplemental Fig. 1B) , we found that similarly to DMyb, Mip130 was present in the nuclei of all proliferating cells, and that its levels fluctuate in the same cell-cycle dependent fashion (Fig. 4B) . Furthermore, the Mip130 protein staining was observed in a punctate pattern which overlapped with that of endogenous DMyb protein (see inset, Fig. 4B ).
The presence of DMyb at fairly uniform levels in proliferating tissues and its degradation during mitosis in embryos and larvae, suggested that like the mitotic cyclins, the continual presence of DMyb might interfere with mitotic exit. Therefore we decided to test whether overexpression of DMyb could abrogate its complete degradation and/or induce any cell cycle abnormalities. When DMyb was overexpressed using the UAS-GAL4 system, we found that DMyb was still present in mitotic cells (Fig. 5) , indicating that overexpression of DMyb can overwhelm the endogenous mechanism responsible for its degradation. Counter to our expectations though, the cells with ectopic DMyb were able to progress through mitosis and no gross cell-cycle defects were apparent (Fig. 5 and not shown). However, closer examination of the staining revealed that in the proximity of the mitotic chromosomes, the level of DMyb was greatly diminished, suggesting that there is a localized degradation or exclusion of the DMyb protein.
As previously reported, a variety of cell-cycle defects, including slower progression through mitosis, have been observed in our two temperature-sensitive mutant alleles, myb 1 and myb 2 , each of which encodes a DMyb protein with a single amino acid change (Fung et al., 2002; Katzen et al., 1998) . We therefore examined the ''behavior'' of the mutant Myb proteins to determine whether any disturbances in the regulation of localization or degradation of these mutant proteins could account for the observed phenotypes. However, we found that like wild type DMyb, the mutant proteins were localized to the nucleus and were degraded just before metaphase during mitosis (data not shown). The mutant proteins also displayed the same subnuclear localization (see below).
2.4.
The degradation of DMyb protein is regulated by the APC/C complex, but not by a Fizzy/Cdc20 or Fzr/Cdh1 mediated mechanism
Since the timing of DMyb degradation in the mitotic domains of Drosophila embryos is similar to what has been reported for Cyclin A (Stiffler et al., 1999) , we examined the relative timings of degradation of these two proteins more directly. Looking at embryos stained simultaneously with antibodies directed against Cyclin A and PH3, we observed that Cyclin A is degraded during metaphase as has been previously reported (Fig. 6A) (Whitfield et al., 1990) . When embryos were doubly stained for Cyclin A and DMyb, we observed that the DMyb and Cyclin A signals disappeared at similar time points during mitosis, although DMyb degradation appeared to precede Cyclin A by a narrow margin (Fig. 6B) . These findings suggest that like Cyclin A and the other mitotic cyclins, DMyb may be degraded by the APC/C.
We investigated whether the APC/C complex is involved in regulating the destruction of DMyb during mitosis. The Drosophila fizzy (fzy) gene encodes an adaptor protein that directs the APC/C to specific substrates, such as the mitotic cyclins, for polyubiquitination and subsequent destruction by the 26S proteasome (Margottin-Goguet et al., 2003) . Fizzy does this by conferring specificity to APC/C activity while simultaneously activating its function. The phenotype of homozygous fzy 1 (null allele) embryos is mitotic arrest in germ band b extended embryos, particularly in the ventral epidermis. This defect is a consequence of elevated levels of Cyclin A due to reduced degradation, which prevents the affected cells from exiting mitosis (Dawson et al., 1993 (Dawson et al., , 1995 Sigrist et al., 1995) . To assess whether Fizzy regulates DMyb degradation, homozygous fzy 1 embryos were stained with antibodies against Cyclin A or DMyb (Fig. 7) . As expected from the previous reports (Dawson et al., 1995) , loss of fzy function prevented normal degradation of Cyclin A during prometaphase and metaphase in ventral epidermal cells, confirming a reduction in Fzy-dependent APC/C function in these embryos (Fig. 7A) . In contrast, DMyb degradation prior to metaphase was unaffected in fzy 1 /fzy 1 embryos, indicating that loss of fzy function does not impair the degradation of DMyb during the cell cycle (Fig. 7A) . As an alternative approach to investigating a possible role of Fzy in DMyb degradation, we used the prd-GAL4 line to drive UAS-fzy expression in alternating segments of germ band extended embryos. As anticipated, we observed a decrease in Cyclin A levels in segments expressing Fzy, but no differences in the levels of DMyb protein were detected between Fizzy expressing and non-expressing segments; nor was there any indication of premature degradation of DMyb during the cell cycle (Fig. 7B) . Thus, Fizzy is not able to promote DMyb degradation when overexpressed. Fzr/Cdh1 is another adaptor protein for the APC/C that regulates the degradation of Cyclins A and B during Drosophila development. As with Fzy, neither loss of Fzr/Cdh1 function, nor overexpression of Fzr resulted in changes of DMyb degradation during mitosis (Supplemental Fig. 3) . Therefore, although the timing of DMyb degradation suggests that it is subject to APC/C degradation, neither of the known adaptor molecules appear to be required for this process.
Since alterations in neither Fizzy nor Fizzy-related protein function resulted in changes in DMyb degradation, we investigated whether reductions in the function of Cdc27, a core component of the APC/C protein complex could affect the process. In preblastoderm embryos derived from females where the maternal contribution of Cdc27 was reduced by one-half, DMyb was still present in metaphase nuclei, indicating a lack of degradation during mitosis (Fig. 7C) . Therefore, we conclude that although known APC/C adaptor proteins do not appear to be involved in DMyb protein degradation, function of the core APC/C protein complex is required.
Subnuclear distribution of DMyb
In addition to investigating the specific timing of DMyb degradation during the cell cycle, we examined the subcellular localization of DMyb during the stages when it was present. As already noted, DMyb was always localized to the nucleus, but closer examination of larval tissues revealed a distinct subnuclear distribution of the DMyb protein. DMyb was excluded from a region of the nucleus that stains especially brightly with DAPI (Fig. 8) . This subnuclear localization was observed in all cells in the brain and imaginal discs (as well as second instar larval salivary glands), but was most readily apparent in the peripodial cells of imaginal discs. These are mitotically active cells which form a squamous epithelial layer over the ''disc proper cells'' that make up the Fig. 5 -Localization of ectopically expressed DMyb. DMyb was ectopically expressed using the binary UAS-GAL4 system in the wing disc. Full length DMyb (top) or C-terminally truncated (activated, DDMyb; bottom) transgenic constructs were driven by the en-GAL4 line, which drives expression in the posterior compartment. Discs were doubly stained with dN-17 DMyb antisera (red in merged images) and DAPI to visualize nuclei (green in merged images). Mitotic cells in metaphase are indicated by arrows. Neither ectopic DMyb nor DDMyb was completely degraded during mitosis; instead, DMyb was detected in the cytoplasm after nuclear membrane breakdown. While this contrasts with the results observed for endogenous DMyb, which was completely degraded by metaphase, it was also evident that DMyb levels were dramatically reduced in the vicinity of the mitotic chromosomes when either transgenic construct was expressed. Scale bar: 0.005 mm. majority of the imaginal tissue (Adler and MacQueen, 1984) . The flattened nuclei of peripodial cells allow the subnuclear architecture to be readily visualized. A similar subnuclear distribution was observed for Mip130 in post-cellularized embryonic (Fig. 8B ) and larval tissues, suggesting that the entire Myb complex is excluded from this region.
In endoreplicating tissues, it has been previously demonstrated that regions of the nucleus with intense DAPI staining (chromocenter) correlate with heterochromatin (Schwed et al., 2002) . Therefore, this observation prompted us to investigate whether DMyb subcellular localization is related to a particular state of chromatin. Centromeric and telomeric DNA sequences are the main constituents of heterochromatin, whereas euchromatin is largely composed of actively transcribed regions of the genome. These two different chromatin states can be distinguished by modifications of particular histone residues: dimethylation of lysine 9 of histone H3 (H3K9Me 2 ) is a marker of heterochromatin, whereas dimethylation of lysine 4 of histone H3 (H3K4Me 2 ) is a marker of euchromatin (Ebert et al., 2004) . Heterochromatin can also be distinguished from euchromatin by the presence of Heterochromatin Protein 1 (HP1), which is associated with het- , and Cyclin A antibodies (green in merge). Staining demonstrates that Cyclin A was degraded during metaphase in mitotic domains as has previously been shown (Stiffler et al., 1999) . Mitotic domains 1 (right) and 2 (left) (as established in Foe, 1989) are outlined. (B) Wild type embryos were stained with DMyb(R1.25) antisera (red in merge), Cyclin A antibodies (green in merge), and DAPI (blue in merge). This staining reveals that DMyb was degraded at nearly the same timepoint in mitosis as Cyclin A. However, DMyb appeared to be degraded slightly earlier during prometaphase as compared to Cyclin A, which is degraded during metaphase (arrows). Mitotic domains 5 (right) and 6 (left) outlined. Scale bar: 0.01 mm.
erochromatin found at centromeres and telomeres (Badugu et al., 2005) . We found that the DMyb was present throughout euchromatic regions of chromosomes as evidenced by costaining with H3K4Me 2 antibodies (Fig. 8A) . However, no overlap was observed between DMyb and H3K9Me 2 staining, suggesting that DMyb is either actively recruited to euchromatic regions or excluded from heterochromatin (Fig. 8A) . These results were recapitulated in later stage embryos and in wing disc proper cells (data not shown). Interestingly, in the endoreplicating nuclei of second instar larval salivary glands, the endogenous DMyb protein was also excluded from heterochromatin (data not shown). The correlation of DMyb with a specific chromatin state was further supported by the lack of subnuclear localization in syncytial embryos (Fig. 1A) , a stage at which heterochromatin has not yet been established (Mahowald and Hardy, 1985; Vlassova et al., 1991) .
To investigate whether DMyb localization is being regulated by the chromatin state of the DNA, we examined DMyb in mutants known to alter the state of chromatin in interphase nuclei. Su(var)3-9 is a histone methyltransferase which selectively methylates the lysine-9 residue of histone H3. As such, mutations in this gene act as a dominant modifier of heterochromatic gene silencing and position effect variegation (PEV) (Ebert et al., 2004) . It has been shown previously that in Su(var)3-9 null mutants, H3-K9 methylation at the chromocenter is severely reduced in larval salivary gland polytene chromosomes, and undetectable in 0-to 12-h embryos (Ebert et al., 2004; Schotta et al., 2002) .
Su(var)3-9 1 and Su(var)3-9 2 are alleles of Su(var)3-9 which are strong dominant suppressors of PEV. We found that H3-K9 dimethylation was significantly reduced in the peripodial cells of Su(var)3-9 1 /Su(var)3-9 2 transheterozygous mutants (Fig. 8) . Furthermore, there was a clear reduction in HP1 (heterochromatin protein 1) staining, confirming that in these mutant peripodial cells, heterochromatin formation has been reduced. However, no change in the subnuclear distribution of DMyb was observed in Su(var)3-9 1 /Su(var)3-9 2 mutants, indicating that neither H3-K9 dimethylation nor HP1 are involved in excluding DMyb from heterochromatic regions.
Discussion
DMyb protein and the cell cycle
Using immunohistochemical analysis we have investigated the distribution and subcellular localization of the endogenous DMyb protein in canonical and modified cell cycles during embryonic and larval development. We found that when present, DMyb is localized to the nucleus in all cell types examined. In agreement with our previously reported results for Dm myb transcripts (Katzen and Bishop, 1996) , the DMyb protein is present in all actively proliferating cells (as well as some non-proliferating cells). We did not detect DMyb in the polyploid tissues of late third instar larvae, which also reflects the transcript results. However, we were able to detect DMyb protein in the polyploid tissues of younger larvae, which are undergoing more active endoreplication. This finding suggests that DMyb may have a function in endoreplication, even though previous work has shown that some endoreplication can occur in tissues that are homozygous for a null allele of Dm myb (Beall et al., 2002) . Our previous studies also demonstrated that high levels of ectopically expressed DMyb can suppress endoreplication (Fitzpatrick et al., 2002) . Although this appears contradictory, it is notable that ectopically expressed Cyclin E is a potent inhibitor of endoreplication, even though Cyclin E function is absolutely essential for endoreplication (Lilly and Spradling, 1996) .
As discussed in the Introduction, there is ample evidence showing that mammalian and Drosophila Myb proteins are involved in regulating cell cycle progression, and that the cell cycle is sensitive to both reduced and increased levels of Myb activity. It was therefore surprising that while the transcript levels of all three mammalian Myb genes are tightly regulated in a cell-cycle dependent fashion, this is not the case for Dm myb. We now show that in mitotic cycles, the DMyb protein is unstable and subject to regulation via cell-cycle dependent degradation: DMyb is rapidly degraded during prometaphase of each cycle and only becomes detectable again at the beginning of the subsequent cycle. In contrast, the levels of DMyb do not fluctuate appreciably in actively endoreplicating cells. Taken together, these findings suggest that DMyb degradation may be required to complete mitosis or as part of a mechanism to ''reset'' the next cell cycle.
It is currently unclear whether cell-cycle progression is dependent on DMyb degradation. No cell cycle block was observed when DMyb was overexpressed, even though its detection during metaphase indicated that the degradation machinery could be overwhelmed. On the other hand, the level of ectopic DMyb protein was reduced in the vicinity of mitotic chromosomes, presumably via localized degradation or exclusion, which may have been sufficient to allow the cells to exit from mitosis. The behavior of Cyclin B provides a naturally occurring precedent that supports this possibility. Like the other mitotic cyclins, Cyclin B is normally targeted for complete destruction during mitosis, but its degradation is initially limited to the region around the mitotic spindles during the syncytial blastoderm divisions (Huang and Raff, 1999; Wakefield et al., 2000) . Interestingly, a recent study of an ectopically expressed DMyb-GFP fusion protein showed that at least in the context of imaginal disc cells, it behaves similarly to our findings for the endogenous and ectopically expressed DMyb proteins, including a comparable subnuclear distribution and a more pronounced reduction of GFP signal in the vicinity of the mitotic chromosomes (Manak et al., 2007) .
The existence of cell-cycle specific degradation of DMyb as a mechanism for regulating DMyb activity does not preclude other levels of regulation, such as posttranslational modifications. Indeed, the lack of cyclical DMyb degradation in actively endoreplicating cells, even though continuous overexpression of DMyb has been shown to suppress endoreplication (Fitzpatrick et al., 2002) , suggests that another level of control is likely.
Degradation of DMyb
The mechanism by which DMyb is targeted for degradation during mitosis is an enigma. The specific timing of DMyb degradation, just before metaphase, and the protein's re-sponse to drug treatments (cycloheximide and colchicines) is virtually identical to that of Cyclin A. In addition, as shown by its stabilization in metaphase nuclei of Cdc27 L7123 mutant embryos, DMyb degradation, like that of Cyclin A and the other mitotic cyclins, appears to be dependent on the core components of the APC/C complex. Unlike the mitotic cyclins, however, DMyb degradation was completely unaffected by mutations in either fzy or fzr, which encode the known adaptor proteins for the APC/C. Examination of the DMyb protein sequence for known APC/C targeting motifs revealed a single KEN-box (targeted by Fzr; Pfleger and Kirschner, 2000) and three potential Dboxes (targeted by Fzy), although none of these had an aspartate (D) or asparagine (N) residue at the appropriate position after the RXXL motif (Glotzer et al., 1991) . DMyb does not contain consensus sequences for the other APC/C targeting motifs that have been described more recently (Araki et al., 2005; Castro et al., 2003; Littlepage and Ruderman, 2002) . When overexpressed, no differences in DMyb levels or localization were detected between full length DMyb and the C-terminally truncated DDMyb proteins, even though the latter retains only one of the partial D-Box motifs. Together, these findings suggest that there may be a currently unidentified APC/C adaptor protein responsible for DMyb degradation.
Our finding that DMyb is unstable and rapidly turned over even during S phase, along with previous evidence that DMyb levels are greatly diminished when certain other members of the Myb complex are absent , suggests another possible mechanism for the stage-specific degradation of DMyb during mitosis. During most of the cell cycle, the majority of the DMyb protein may be associated with the other four members of the Myb complex, thereby protecting the complexed DMyb from APC/C degradation. If at prometaphase, there was regulated dissociation of DMyb from the complex or of the entire DMyb complex, then all of the protein would be ''free DMyb'', which would then be highly susceptible to degradation. In light of this model, it is of interest to consider the localization of the four other Myb complex proteins and what occurs to them during mitosis. We have found that Mip130 is degraded during mitosis and that the timing of its disappearance is similar to DMyb in both syncytial and cellularized embryos (Fig. 4) . In contrast, the fate of another complex member, p55/Caf1, differs from DMyb and Mip130 in that the presence of p55/Caf1 can be detected throughout mitosis and the rest of the cell cycle (Tyler et al., 1996) . Although the cell cycle behavior of the other two complex members has yet to be analyzed, these findings indicate that at least a subset of the Myb complex subunits are degraded during mitosis. Biochemical determination of whether the Myb complex dissociates prior to its degradation will be necessary to evaluate the validity of this model.
DMyb and chromatin
The observation that the majority of DMyb and its complex are excluded from heterochromatic regions raises intriguing questions with respect to localization and function. First, how is the subnuclear localization of DMyb controlled? In an effort to address this, we examined DMyb localization in Su(-var)3-9 mutants, which are defective in H3-K9 methylation, resulting in reduced heterochromatin formation. DMyb subnuclear localization was unaffected in these mutants, even though there was a clear reduction in the staining of the heterochromatic protein HP1 at the chromocenter. While this indicates that neither H3-K9 dimethylation nor HP1 are involved in excluding DMyb from heterochromatic regions, the finding that DMyb is localized throughout the nucleus in nuclei where heterochromatin has not yet been established (syncytial blastoderms), strongly suggests that the inverse correlation between heterochromatin and DMyb staining is not coincidental. Additional studies will be required to determine the mechanism by which DMyb is localized within the nucleus. Second, what is the functional significance of this localization? One possibility is that the majority of DMyb might be excluded from heterochromatic regions as a means of exerting tight control on the replication of heterochromatic DNA and/or transcription within heterochromatic regions. Another possibility, which we are investigating, is that DMyb is actively involved in regulating the state of chromatin, promoting euchromatization and inhibiting heterochromatization.
4.
Experimental procedures
Drosophila stocks and manipulation
The mutant Dm myb alleles myb 1 and myb 2 , control white wild type strain, and transgenic lines UAS-DMyb and UAS-DDMyb have been described previously (Fitzpatrick et al., 2002; Katzen and Bishop, 1996; Katzen et al., 1998) . The mip130 1-36 allele has been described previously ; Su(var) 2 /TM3, and prd-GAL4/TM3 stocks were obtained from Bloomington Stock Center. The deficiency Df(1)bi-D3 (a gift from F. Sprenger) removes the fzr gene as well as Fzy resulted in decreased levels of Cyclin A (top row), but not DMyb (bottom row). Germ band extended embryos in which UAS-fzy expression was driven by prd-GAL4, were doubly stained with DAPI (green in merges) and Cyclin A or dN-17 DMyb antisera (red in merges). In paired expressing regions (+prd, outlined), Cyclin A, but not DMyb, protein levels were reduced. (C) DMyb degradation during syncytial development requires the function of the core APC/C component Cdc27. Preblastoderm embryos derived from w (wild type control) and Cdc27
L7123
/+mutant females, nuclear cycle 10, were doubly stained with DAPI (green in merges) and dN-17 DMyb antisera (red in merges). Degradation of DMyb was evident at metaphase in wild type embryos (top row), but was reduced in metaphase nuclei of Cdc27 mutant preblastoderm embryos (bottom row; arrows). Scale bars: 0.01 mm in all panels. 
4.2.
RNA in situ hybridization
Non-radioactive whole mount in situ hybridization was performed with a modified protocol of Jiang et al. (1991) . Sense and anti-sense digoxigenin labeled riboprobes were generated by in vitro transcription of Drosophila myb cDNA using the run-off method. The 0-to 16-h embryos were collected, dechorionated with 50% bleach, fixed in a 3.7% formaldehyde/heptane bilayer and devitillinized by methanol. Embryonic yolk was then cleared by treatment with xylene. The embryos were predigested with 50 lg/ml Proteinase K, refixed with 3.7% formaldehyde, and then prehybridized for 1 hr at 55°C. Hybridization was done with either sense or anti-sense probes overnight at 55°C. After washing, embryos were incubated with preabsorbed anti-digoxigenin AP conjugated antibody (Roche) for 2 h at room temperature. Blue color development was done with NBT (4-nitro blue tetrazolium chloride) (Roche) and BCIP (5-bromo-4-chloro-3-indolyl-phosphate) (Roche).
Immunofluorescence
Immunofluorescence was performed essentially as in Sullivan et al. (2000) . Briefly, embryos were collected and dechorionated with 50% bleach, fixed in a 3.7% formaldehyde/heptane bilayer, and devitillinized by methanol. Then embryos were rehydrated with 0.05% Triton X-100 in 1· PBS (PBST) for 15 min, followed by a washing step in PBST. Primary antibodies were rabbit anti-PH3 (Upstate Biotechnology) diluted 1:1000, rabbit di-methylated H3 lysine 4 antibody (Upstate Biotechnology) diluted 1:100, rabbit di-methylated H3 lysine 9 antibody (Upstate Biotechnology) diluted 1:100, mouse anti-a-tubulin (Serotec) diluted 1:20 mouse anti-HP1 (monoclonal supernatant, C1A9 Developmental Studies Hybridoma Bank at the University of Iowa) diluted 1:5, and mouse anti-cyclin A (monoclonal concentrate, A12, Developmental Studies Hybridoma Bank) diluted 1:100. Primary antibodies directed against the DMyb protein were rabbit anti-DMyb(1.25RI) diluted 1:500, which has been characterized (Jackson et al., 2001 ) and goat anti-dN-17 (Santa Cruz Biotechnology) diluted 1:50, which recognizes 17 N-terminal amino acids of DMyb. Primary rabbit antiMip130 sera (a gift from M. Botchan; 1:500) was described previously in Beall et al., 2004 . Secondary antibodies were diluted 1:200 (Jackson Immunoresearch) . Embryos were counterstained with DAPI (Molecular Probes) and mounted in Vectashield (Vector Laboratories). Staining of imaginal tissue was also performed as in Sullivan et al. (2000) .
Blocking of the dN-17 Anti-Myb antibody was performed according to manufacturer's instructions. Briefly, dN-17 antibody was diluted in PBS to make 2 ml of 1lg/ml. The antibody was divided equally into two tubes. dN-17 blocking peptide (Santa Cruz Biotechnology) was added to one tube to a concentration of 2 lg/ ml. The tubes were incubated at room temperature for 2 h. Both tubes were centrifuged at 10,000 RPM for 10 min at room temperature to sediment any immune complexes. The supernatants were used for immunofluorescence experiments as described above.
Confocal images were obtained using a Zeiss Axiovert 200 M inverted microscope using the LSM5 Pascal Confocal system. Adobe Photoshop 7.0 (Adobe Systems) was used to process all images.
BrdU incorporation
For BrdU (5-bromo-2-deoxyuridine) labeling, second instar salivary glands that were dissected in Schneider's medium (Gibco) were incubated in Schneider's media containing 1 mg/ml BrdU (Sigma) for 1 h. Subsequently, they were fixed as in 8% formaldehyde, diluted in PBS and washed three times in PBST. The samples were then treated with of RQ1 DNase (Promega) 25 U/ml in RQ1 DNAse Buffer (Promega) at 37°C for 30 min, and subsequently washed three times in PBST. Samples were then blocked with 5% normal goat serum (NGS) in PBST and incubated with mouse anti-BrdU monoclonal antibody (Becton-Dickinson) diluted 1:20. Secondary antibodies conjugated to rhodamine (Jackson) were used at a dilution of 1:200. After BrdU staining, the sample were stained with DAPI and mounted as described above.
DMyb protein degradation/turnover
Cell-cycle staging: embryos were treated essentially as described in Su et al. (1999) . Briefly, embryos were collected for 60 min at 25°C. Embryos were dechorionated in 50% bleach and rapidly devitellinized and fixed in a two phase mixture of pure methanol and PBS. Embryos were then stained for DNA with 4 lg/ml Hoechst 33258. The mitotic phases of the nuclei in the embryos were distinguished using a UV illumination on a Zeiss compound microscope. Embryos in interphase, metaphase, and anaphase/telophase (combined) during nuclear division cycles 8-12 were sorted and pooled. Approximately equal numbers of embryos were homogenized in Laemmli buffer. Embryos showing signs of significantly asynchronous mitoses were excluded. Samples were immunoblotted as described below.
Drug treatments: embryos were dechorionated and permeabilized with octane as described previously (Edgar and O'Farrell, 1990) . Permeabilized embryos were incubated in Schneider's tissue culture medium containing, 20 lg/ml cycloheximide for 30 min, or treated with 50 lg/ml colchicine first for 20 min and then with 20 lg/ml cycloheximide for 30 min (stock solutions dissolved in DMSO). Control embryos were permeabilized and incubated in Schneider's media containing DMSO only were used. A portion of embryos were fixed and stained with DAPI to visualize DNA in order to confirm that the expected cell cycle arrest had . Discs were stained with DAPI to visualize DNA (blue in all merges) and DMyb dN-17 antibodies (green in all merges). In wild type nuclei (1st row), there was complete colocalization between DMyb and an antibody specifically directed against dimethylation of lysine 4 of Histone H3 (H3K4Me2), a marker for euchromatin. In contrast, DMyb was completely excluded from heterochromatic regions labeled with an antibody specifically directed against dimethylation of lysine 9 of Histone H3 (H3K9Me2; 2nd row). A similar result was obtained when staining for both DMyb and Heterochromatic Protein 1 (HP1), a heterochromatic associated protein (3rd row). DMyb localization was unaltered in a Su(var)3-9 mutant, even though dimethylation of lysine 9 of Histone H3 (4th row) and localization of HP1 (5th row) were disrupted. (B) In wild type embryos Mip130 protein is excluded from heterochromatic regions in epidermal and amnioserosal cells (arrow). Scale bars: 0.005 mm in all panels. b been reached. Approximately equal numbers of embryos were homogenized in HEMG buffer (Su et al., 1999 ). An equal amount of SDS gel loading buffer was added and the sample was boiled for 10 min. Samples were electrophoresed on 8% SDS gels and western blotted according to standard procedures. Western blots were probed with rabbit polyclonal antibodies against DMyb, 1:1000 (1.25RI) (Jackson et al., 2001) ; mouse monoclonal antibodies against Drosophila cyclin A (Developmental Studies Hybridoma Bank), 0.5 lg/ml final concentration; or mouse monoclonal antibodies against a-tubulin (Sigma), 1:1000.
